Featured
Status
Health Topics
Any CategoryDiseases
Pathological Conditions, Signs and Symptoms
-
- Arrhythmias, Cardiac 1
- Ascites 2
- Chromosome Aberrations 1
- Death 2
- Delayed Graft Function 1
- Disease 79
- Disease Attributes 15
- Dysbiosis 1
- Fibrosis 3
- Frailty 3
- Granuloma 1
- Growth Disorders 3
- Hemolysis 1
- Hemorrhage 16
- Hyperplasia 1
- Inflammation 18
- Ischemia 1
- Menstruation Disturbances 3
- Muscle Weakness 5
- Necrosis 1
- Postoperative Complications 19
- Sclerosis 3
- Shock 2
- Ulcer 4
Search Clinical Trials
Recruiting
Safety and Efficacy of Endoscopic Assisted Push Gastrostomy Using Gastrostomy Technique (External Link)
This is a retrospective chart review. We will review charts of patients who underwent gastrostomy with gastropexy and primary percutaneous gastrostomy tube placement with pull through technique and compare immediate …
Baylor Role:
Collaborator
Completed
Assessment Of Educational Strategies In Heart Failure Patients Presenting To The Emergency Department For Care (External Link)
In 2015, 12.8% of adults ages 19-64 in the United States lacked any form of health insurance. An even greater number fell under the umbrella of under-insured. Studies indicate that …
Baylor Role:
Lead Sponsor
Recruiting
BBD Longitudinal Study of Osteogenesis Imperfecta (External Link)
The purpose of this natural history study is to perform a long-term follow-up of a large group of people with osteogenesis imperfecta (OI). The research aims are: 1. To collect …
Baylor Role:
Lead Sponsor
Completed
Fast-Fail Trials in Mood and Anxiety Spectrum Disorders; Kappa Opioid Receptor Phase 2a (External Link)
FAST-MAS addresses an important problem and critical barrier to progress in Mood and Anxiety Spectrum Disorders and if the aims of the project are achieved, FAST-MAS could shift scientific knowledge, …
Baylor Role:
Collaborator
Completed
Home Away From Home - Medical Outcomes (External Link)
This is a bidirectional observational cohort study. Participants will be patients less that 19 years of age at diagnosis receiving or having received chemotherapy for AML from seventeen participating pediatric …
Baylor Role:
Collaborator
Completed
Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders (External Link)
The standard of care in patients receiving rituximab is to give the dose slowly and gradually increase the rate of rituximab until the full dose is given, which may take …
Baylor Role:
Lead Sponsor
Completed
Genomic Sequencing for Childhood Risk and Newborn Illness (External Link)
The objective of this research protocol is to conduct a randomized clinical trial to assess the benefits and risks of adding the information from a genomic sequencing report to physician-mediated …
Baylor Role:
Collaborator
Terminated
Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome (External Link)
This pilot study investigates clinical benefit of four 28-day cycles of sertraline in low-risk MDS patients. Participants will receive 100mg of oral sertraline daily. The study will also evaluate potential …
Baylor Role:
Collaborator
Completed
Energetics and Function in Older Humans (External Link)
Data not available at present
Baylor Role:
Lead Sponsor
Completed
Comparative Efficacy of Phenylbutyrate (PBA) vs. Benzoate in Urea Cycle Disorders (External Link)
The investigators will study and compare how effectively sodium phenylbutyrate, sodium benzoate, and a combination of the two, help excrete nitrogen in healthy volunteers. Subject participation will require three, separate, …
Baylor Role:
Lead Sponsor